Could Canopy Growth Corp (TSX:WEED) Fall Below $50?

Canopy Growth Corp (TSX:WEED)(NYSE:CGC) has been struggling over the past three months and things might not be getting better anytime soon.

| More on:
Handwriting text writing Are You Ready For Tomorrow question. Concept meaning Preparation to the future Motivation Stand blackboard with white words behind blurry blue paper lobs woody floor.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

The hype for marijuana stocks has been strong in recent years. However, not everyone is sold on their ability to meet the expectations that Wall Street has set for them. With a lot of hurdles present in the cannabis industry and many hiccups since legalization, it hasn’t been smooth sailing.

Canopy Growth Corp (TSX:WEED)(NYSE:CGC) has been no exception to that with the company initially hoping to open many stores in its home province to now being very limited as a result of restrictions Ontario has placed on producers. It’s but one example of where things haven’t gone according to plan, and it’s the big producers that are going to be feeling the worst of it.

Analysts have started to notice this as well. Last week, Scotiabank analysts cut their estimates for Canopy Growth’s sales by as much as 26% on concerns that expectations have been too optimistic. The analysts noted said that they “expect aggregate calendar year first-quarter 2019 cannabis revenue to be below fourth-quarter 2018, while the street is looking for a 35 per cent increase.”

It wouldn’t be the first time that we learned estimates were too high. When Canopy Growth released its Q2 results in November, it missed expectations by a mile and came nowhere near even the low end of what was being projected. And it hasn’t been the only company, as earlier this year, Aurora Cannabis Inc gave investors an early warning that its sales for the upcoming quarter were going to be much lower than expected.

Part of the problem is that cannabis is a new industry, and with sales previously being in the black market, getting accurate numbers was always going to be a challenge. And with supply issues a big impediment to the industry’s growth, resulting in a limited amount of stores being open, it has contributed led to softer sales for the recreational market as well.

Is Canopy Growth headed lower?     

Canopy Growth’s share price has been dropping over the past few weeks, and while there may be a temptation to buy the dip, there’s a very real possibility that this could be the start of a bigger correction.

From having strong support at $60, Canopy Growth has seen investors lose faith in the stock, as support levels have been shifting down and even dropping below $50 doesn’t seem unrealistic at this point. Ultimately, it’ll come down to the company’s next earnings report, which will dictate how much of a correction (or rally) we’ll see from the stock.

If Canopy Growth knocks it out of the park, it could send the stock back up in a big way. However, given the way things have gone, I wouldn’t count on that happening. The other problem is that another big miss could have devastating results not only the stock, but also on the industry as a whole, as investors may lose confidence in any sort of projections going forward.

Now that analysts are becoming more bearish on the industry, it could be a sign that the tide is turning — and even beverages may not be able to save the stock now.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor David Jagielski has no position in any of the stocks mentioned. Scotiabank is a recommendation of Stock Advisor Canada.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »